New hope for tough prostate cancer: drug cocktails under trial
NCT ID NCT02703623
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests different combinations of approved drugs in 196 men with advanced prostate cancer that has spread and no longer responds to hormone therapy. The goal is to see which combinations work best to extend life and control the cancer. Participants receive standard hormone-blocking drugs with or without additional immunotherapy or chemotherapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CASTRATION LEVELS OF TESTOSTERONE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
-
MD Anderson in Katy
Houston, Texas, 77094, United States
-
MD Anderson in Sugar Land
Sugar Land, Texas, 77478, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a tracer that hunts unstable iron light up hidden tumors?
- Can a three-drug cocktail outsmart resistant prostate cancer?
- New hope for advanced bladder cancer? bevacizumab combo tested
- Supercharged immune cells take on Hard-to-Treat prostate cancer
- New combo therapy aims to delay return of spread prostate cancer
- New PET scan agent aims to map hidden prostate cancer spread